Statement on H.R. 1: Medicaid cuts threaten vulnerable patients
July 09, 2025
Read statement
Octapharma Plasma
The family-owned company, Octapharma AG, was established in 1983 with a single idea: that people with Hemophilia deserve access to better treatments.
Jerry Winkelstein helped build IDF’s respected reputation
July 02, 2025
Read article
Foundation Focus: June 2025 update with CEO Jorey Berry
June 30, 2025
Listen to podcast
Financial assistance programs can help with medical bills
June 25, 2025
Read article
Foundation sends letter opposing research cuts
June 16, 2025
Download letter
How Medicaid cuts could impact a family affected by SCID
June 16, 2025
Read article
Lunch & Learn: Understanding genetic variants in APDS
June 10, 2025
Listen to podcast
Update: What RSV preventatives mean for those with PI
June 10, 2025
Read article
Genentech
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
